GoKawiil
Tech News
A commentary argues that with Democrats poised to gain control of the House and Senate, lawmakers should pursue impeachment proceedings against Robert F. Kennedy Jr. The piece frames this as a priority once Democrats hold majorities in both chambers.
HHS Secretary Robert F. Kennedy Jr. has directed the FDA to refrain from taking enforcement action against pharmacies selling six compounded peptides, including BPC-157, KPV and TB-500. The Associated Press reports the decision was made without input from FDA scientists, who generally opposed the change, and HHS says it is intended to expand patient choice while maintaining safety.
Health Secretary Robert F. Kennedy Jr. has issued a Department of Health and Human Services policy stating it will not take enforcement action against compounding pharmacies that produce and sell six peptides—BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. The move does not formally change the drugs' regulatory status, but effectively reverses a 2023 FDA decision that removed those peptides from the approved list for compounding due to safety and efficacy concerns. The policy was posted to the Federal Register this week, with final publication set for October 30.
At a board meeting overseeing the NIH Clinical Center Research Hospital, chair Jack Leslie spent six minutes criticizing Health Secretary Robert F. Kennedy Jr. over a ribbon-cutting event for a new vaccine injury clinic, which featured a panel of people claiming vaccine injuries. Hospital CEO Jonathan Green clarified that the NIH already studies vaccine safety and that Kennedy's clinic is simply a new treatment protocol, not an expansion of funding or space.
Calley Means, a senior advisor to Health Secretary Robert F. Kennedy Jr. and co-author of the MAHA movement's policy framework, announced his resignation from the Trump administration on Thursday. He credited himself with advancing initiatives like dietary guideline reforms, removing soda from SNAP and banning food dyes, but gave no public reason for leaving.
Guinea-Bissau's Council of Ministers reaffirmed on October 16 that it will not allow a clinical trial led by Danish researcher Christine Stabell Benn of Bandim Health Project, which was to be funded by the US and would have withheld the newborn hepatitis B vaccine dose from half its infant participants. The rejection followed a judicial police raid on Bandim Health's offices in which vaccines were seized, though Stabell Benn noted the raid came after the government's decision.
Police in Guinea-Bissau seized hepatitis B vaccine doses from the offices of Danish researchers Peter Aaby and Christine Stabell Benn, who had been planning a newborn vaccine trial. The trial, criticized by international health experts as unethical, was backed by a $1.6 million CDC grant awarded under HHS Secretary Robert F. Kennedy Jr. in December, and plans were paused in January amid widespread condemnation, though a Rolling Stone report this month said the CDC had set aside further funding to proceed.
TikTok has begun returning a 'no results found' page when users search for specific peptide names like semaglutide, BPC-157 and retratutide, though videos discussing peptides remain viewable and searchable under the general term. Influencer Jeff Tang flagged the change, and TikTok's parent company did not immediately respond to a request for comment.
The FDA has submitted an 'Interim Access Policy' on peptide drugs to the White House for review, according to people familiar with the matter cited by the Associated Press. The policy would reportedly let the agency decline to enforce existing restrictions on certain peptides, reassuring compounding pharmacies that they won't face enforcement action if they begin producing them. This comes as FDA scientists are re-reviewing a dozen peptide drugs previously found in 2023 to lack sufficient safety and efficacy data.
The Department of Health and Human Services announced an agency-wide initiative under Secretary Robert F. Kennedy Jr. focused on identifying vaccine-related injuries. The plan includes a new NIH clinic for patients reporting post-vaccination health problems, which quietly opened October 5 with Kennedy in attendance, plus a proposal to pay doctors for submitting reports to the CDC's Vaccine Adverse Event Reporting System (VAERS).
Health Secretary Robert F. Kennedy Jr. recently endorsed artificial intelligence as a tool for individuals to verify their medical advice and reduce reliance on authorities. His stance has sparked criticism from both MAHA allies, who see it as a departure from their traditional skepticism of corporate influence, and medical experts, who argue that AI's capabilities are misunderstood. Kennedy's advocacy positions AI as a means for Americans to better understand and manage their health data independently.
A report on the Make America Healthy Again Summit, hosted under Health and Human Services Secretary Robert F. Kennedy Jr., describes it as sponsored by corporate interests and featuring attendees including people convicted of or awaiting trial for serious crimes. The piece frames the event as emblematic of Kennedy's broader approach to leading U.S. health policy despite his history of promoting vaccine skepticism and other fringe health claims.